等待開盤 09-18 09:30:00 美东时间
+0.051
+0.13%
国产“芯片一哥”明起复牌,PCB概念股异动期间实控人减持30万股公司股份,这一机器人概念股控制权恐生变......
09-08 21:17
Pelthos Therapeutics Inc. announced that its CEO, Scott Plesha, and CFO, Frank Knuettel, will present at the Wells Fargo Healthcare Conference on September 3, 2025, at 1:30 p.m. ET. The presentation will be available via webcast on Pelthos' website, with an archive available for 90 days. Pelthos, a biopharmaceutical company, focuses on innovative therapeutic products, with its lead product, ZELSUVMI™, approved for molluscum contagiosum treatment.
09-02 12:00
Ascendis Pharma A/S (NASDAQ:ASND) today announced two oral presentations at ENDO 2025, the annual meeting of the Endocrine Society being held July 12-15, 2025, in San Francisco. Dr. Aliya Khan will present new data from
07-08 04:03
Channel Therapeutics shares rise after announcing 10-for-1 reverse stock split and upcoming rebrand.
06-27 23:55
4 analysts have shared their evaluations of Septerna (NASDAQ:SEPN) during the r...
06-23 20:02
Needham analyst initiates coverage on Hims & Hers Health, Inc. with a Buy rating and $24 price target. Anticipates positive impact from GLP-1 market entry and strong growth potential.
2024-08-23 02:26